Allergan Aesthetics launches new AA signature program at IMCAS 2025
- Allergan Aesthetics, an AbbVie (NYSE:ABBV) company, Tuesday unveiled the new AA signature program at IMCAS World Congress 2025, an approach that focuses on key patient needs frequently seen in clinical practice.
- The program provides HCPs with advanced training and education